Raftlin-2 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of Raftlin-2, a protein known for its role in lipid raft organization within cell membranes. Lipid rafts are specialized microdomains rich in cholesterol and sphingolipids, serving as platforms for various signaling molecules and proteins involved in cellular communication and membrane trafficking. Raftlin-2 is thought to be involved in the regulation of these lipid rafts, influencing their formation, stability, and the clustering of signaling proteins. By inhibiting Raftlin-2, these compounds can alter the dynamic properties of lipid rafts, thereby modulating the organization of membrane proteins and the signaling events that occur within these domains.
The mechanisms by which Raftlin-2 inhibitors function typically involve interfering with the protein's ability to associate with lipid membranes or its capacity to regulate the distribution of lipids within the membrane. Some inhibitors may bind to Raftlin-2 directly, preventing its interaction with the lipid raft components, while others may modify the protein's structure, impairing its function in raft organization. Researchers use Raftlin-2 inhibitors to study the role of lipid rafts in processes such as signal transduction, membrane trafficking, and protein sorting. By inhibiting Raftlin-2, scientists gain valuable insights into how lipid raft dynamics contribute to cellular communication and organization. The use of these inhibitors is crucial for understanding the broader implications of membrane microdomain regulation in various cellular processes, particularly in how cells control the localization and function of signaling molecules within the plasma membrane.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-Hydroxypropyl-β-cyclodextrin | 128446-35-5 | sc-203461 sc-203461B sc-203461C sc-203461A | 1 g 100 g 500 g 5 g | $52.00 $620.00 $1950.00 $130.00 | 8 | |
Extracts cholesterol from lipid rafts, potentially disrupting raft integrity and associated proteins. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $116.00 $145.00 | 26 | |
Binds to cholesterol, destabilizing lipid rafts and affecting raft-associated proteins. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Inhibits HMG-CoA reductase, reducing cholesterol synthesis and potentially altering lipid rafts. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
Another HMG-CoA reductase inhibitor, affecting cholesterol levels and lipid raft composition. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $252.00 $495.00 | 9 | |
Lowers cholesterol production, which can influence the structure and function of lipid rafts. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $142.00 | 8 | |
Reduces cholesterol synthesis, possibly affecting lipid raft-dependent signaling pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Isoflavone that can disrupt lipid raft localization of proteins by interfering with raft cholesterol. | ||||||
Amphotericin B | 1397-89-3 | sc-202462 sc-202462A sc-202462B | 100 mg 500 mg 1 g | $69.00 $139.00 $219.00 | 10 | |
Antifungal that interacts with ergosterol and cholesterol, affecting membrane integrity including rafts. | ||||||
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $45.00 $60.00 $115.00 $170.00 $520.00 | 36 | |
Sulfonylurea compound that can interfere with certain signaling pathways associated with lipid rafts. | ||||||